D2R awards $10 million to accelerate RNA-based therapies for rare diseases and cancer
McGill University’s DNA to RNA Initiative (D2R) has awarded over $10 million to support three pioneering RNA-based research projects aimed at advancing therapies for rare genetic diseases and cancers.